Curirxincis A Certified Minority Woman Owned Pharmaceutical Contract Researchdevelopmentand Manufacturing Organizationcrdmobased In Wilmingtonmassachusettsfounded In 2012The Company Operates From A 13 000 Square Foot Facility And Is Staffed By Phd Level Scientists With Extensive Industry Experience Curirx Specializes In End To End Drug Development Solutionsparticularly In Formulation Development And Commercialization Supporttheir Services Include Expertise In High Concentration Monoclonal Antibodiesbispecific Antibodiesand Peptidesas Well As Comprehensive Support For Injectablesthe Company Focuses On Innovative Methodologies To Reduce Costs And Lead Times While Maintaining High Qualitycurirx Collaborates With Various Biopharmaceutical Companiesproviding Valuable Contributions To Projects And Enhancing Therapeutic Standards Through A Commitment To Respectprofessionalismand Agility
